# Asset Medikal Tasarim As.

- Location (FDA's records): Istanbul, TR
- FDA decisions: 4 (2020–2022): 4 510(k) clearances
- Product codes: FPA (4)
- 510(k) review time since 2016: median 156 days, against 213 for FDA's reviews in the same codes and years (3 of 4 faster)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K221473: Flowart (Sep 26, 2022)
- K221481: NeutrArt (Sep 23, 2022)
- K201872: NeutrArt (Jan 5, 2021)
- K190806: Flowart (Feb 20, 2020)

Source page: https://510kreport.com/company/asset-medikal-tasarim